Oncosil Medical Ltd (OSL)

Sydney
0.052
0.000(0.00%)
  • Volume:
    552,148
  • Bid/Ask:
    0.052/0.053
  • Day's Range:
    0.053 - 0.054

OSL Overview

Prev. Close
0.053
Day's Range
0.053-0.054
Revenue
1.38M
Open
0.054
52 wk Range
0.041-0.18
EPS
-0.01
Volume
552,148
Market Cap
41.6M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
1,576,760
P/E Ratio
-
Beta
0.41
1-Year Change
-61.48%
Shares Outstanding
792,343,294
Next Earnings Date
20 Feb 2022
What is your sentiment on Oncosil Medical Ltd?
or
Vote to see community's results!

Oncosil Medical Ltd News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyBuySell
Technical IndicatorsSellStrong SellStrong SellStrong BuyStrong Sell
SummaryNeutralNeutralNeutralStrong BuyStrong Sell

Oncosil Medical Ltd Company Profile

Oncosil Medical Ltd Company Profile

Employees
2
Market
Australia

OncoSil Medical Limited, a medical device company, focuses on the development and commercialization of localized radiation therapy for the treatment of pancreatic and bile duct cancer in Australia. Its lead product is OncoSil, a brachytherapy device indicated for the treatment of patients with locally advanced unresectable pancreatic cancer, in combination with gemcitabine-based chemotherapy. The company was formerly known as NeuroDiscovery Limited and changed its name to OncoSil Medical Limited in May 2013. OncoSil Medical Limited was incorporated in 2005 and is headquartered in North Sydney, Australia.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.